Cargando…

SuPAR correlates with mortality and clinical severity in patients with necrotizing soft-tissue infections: results from a prospective, observational cohort study

Necrotizing soft tissue infections (NSTI) have a 90-day mortality rate of 18–22%. Tools are needed for estimating the prognosis and severity of NSTI upon admission. We evaluated soluble urokinase-type plasminogen activator receptor (suPAR) levels at admission as a prognostic marker of NSTI severity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polzik, Peter, Grøndal, Olav, Tavenier, Juliette, Madsen, Martin B., Andersen, Ove, Hedetoft, Morten, Hyldegaard, Ole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434142/ https://www.ncbi.nlm.nih.gov/pubmed/30911053 http://dx.doi.org/10.1038/s41598-019-41688-y

Ejemplares similares

Hyperbaric oxygen treatment is associated with a decrease in cytokine levels in patients with necrotizing soft‐tissue infection
por: Hedetoft, Morten, et al.
Publicado: (2021)

Associations between YKL-40 and markers of disease severity and death in patients with necrotizing soft-tissue infection
por: Hedetoft, Morten, et al.
Publicado: (2021)

Healthy lifestyles reduce suPAR and mortality in a Danish general population study
por: Haupt, Thomas Huneck, et al.
Publicado: (2019)

suPAR and Team Nephrology
por: Trachtman, Howard
Publicado: (2014)

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis
por: Garnæs, Emilie, et al.
Publicado: (2019)

Incidence, comorbidity and mortality in patients with necrotising soft-tissue infections, 2005–2018: a Danish nationwide register-based cohort study
por: Hedetoft, Morten, et al.
Publicado: (2020)

Hyperbaric oxygen treatment impacts oxidative stress markers in patients with necrotizing soft-tissue infection
por: Hedetoft, Morten, et al.
Publicado: (2021)

Hyperbaric oxygen treatment in the management of necrotising soft-tissue infections: results from a Danish nationwide registry study
por: Hedetoft, Morten, et al.
Publicado: (2023)

Increase in the Complement Activation Product C4d and the Terminal Complement Complex sC5b-9 Is Associated with Disease Severity and a Fatal Outcome in Necrotizing Soft-Tissue Infection
por: Hedetoft, Morten, et al.
Publicado: (2021)

Key pathways and genes that are altered during treatment with hyperbaric oxygen in patients with sepsis due to necrotizing soft tissue infection (HBOmic study)
por: Vinkel, Julie, et al.
Publicado: (2023)

suPAR: The Molecular Crystal Ball
por: Thunø, Maria, et al.
Publicado: (2009)

suPAR: An Inflammatory Mediator for Kidneys
por: Sudhini, Yashwanth Reddy, et al.
Publicado: (2022)

Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients
por: Iversen, Esben, et al.
Publicado: (2020)

Investigating the Effects of Hyperbaric Oxygen Treatment in Necrotizing Soft Tissue Infection With Transcriptomics and Machine Learning (the HBOmic Study): Protocol for a Prospective Cohort Study With Data Validation
por: Vinkel, Julie, et al.
Publicado: (2022)

High suPAR and Low Blood Eosinophil Count are Risk Factors for Hospital Readmission and Mortality in Patients with COPD
por: Håkansson, Kjell E J, et al.
Publicado: (2020)

suPAR as a prognostic biomarker in sepsis
por: Donadello, Katia, et al.
Publicado: (2012)

Reassessing the Reassessment of suPAR in Glomerular Disease
por: Meijers, Björn K. I., et al.
Publicado: (2015)

suPAR to Risk-Stratify Patients With Malaria
por: Stefanova, Veselina, et al.
Publicado: (2022)

The biomarkers suPAR and blood eosinophils are associated with hospital readmissions and mortality in asthma – a retrospective cohort study
por: Håkansson, K. E. J., et al.
Publicado: (2019)

Utility of the Plasma Level of suPAR in Monitoring Risk of Mortality during TB Treatment
por: Rabna, Paulo, et al.
Publicado: (2012)

suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19
por: Altintas, Izzet, et al.
Publicado: (2021)

suPAR, a Circulating Kidney Disease Factor
por: Wei, Changli, et al.
Publicado: (2021)

SuPAR predicts postoperative complications and mortality in patients with asymptomatic aortic stenosis
por: Hodges, Gethin W, et al.
Publicado: (2018)

Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study
por: Haupt, Thomas Huneck, et al.
Publicado: (2012)

The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine Perspective
por: Benucci, Maurizio, et al.
Publicado: (2022)

Role of suPAR and Lactic Acid in Diagnosing Sepsis and Predicting Mortality in Elderly Patients
por: Khater, Walaa S., et al.
Publicado: (2016)

SuPAR - A future prognostic biomarker in emergency medicine
por: Østervig, Rebecca M, et al.
Publicado: (2015)

suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients
por: Meyer, Jeppe, et al.
Publicado: (2018)

suPAR remains uninfluenced by surgery in septic patients with bloodstream infection
por: Rabensteiner, Jasmin, et al.
Publicado: (2016)

suPAR Surprises as a Biomarker of Invasive Outcomes in Pleural Infection
por: Idell, Steven, et al.
Publicado: (2020)

The Perspective of Vitamin D on suPAR-Related AKI in COVID-19
por: Liao, Tzu-Hsien, et al.
Publicado: (2022)

The Association of suPAR with Cardiovascular Risk Factors in Young and Healthy Adults
por: Wohlwend, Niklas Fabio, et al.
Publicado: (2023)

Utility of suPAR and NGAL for AKI Risk Stratification and Early Optimization of Renal Risk Medications among Older Patients in the Emergency Department
por: Walls, Anne Byriel, et al.
Publicado: (2021)

Complement Activation Is Associated With Mortality in Patients With Necrotizing Soft-Tissue Infections—A Prospective Observational Study
por: Kristensen, Markus Korsholm, et al.
Publicado: (2020)

Detection of suPAR in the Saliva of Healthy Young Adults: Comparison with Plasma Levels
por: Gustafsson, Anna, et al.
Publicado: (2011)

Plasma levels of the active form of suPAR are associated with COVID-19 severity
por: Huang, Mingxiang, et al.
Publicado: (2020)

Assay-related differences in SuPAR levels: implications for measurement and data interpretation
por: Vasbinder, Alexi, et al.
Publicado: (2022)

Predictive value of suPAR in AKI: a systematic review and meta-analysis
por: Huang, Yan, et al.
Publicado: (2022)

Soluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update
por: Velissaris, Dimitrios, et al.
Publicado: (2022)

SuPAR mediates viral response proteinuria by rapidly changing podocyte function
por: Wei, Changli, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f07ebc23vh31r4c93gr4s47hac